鹿児島大学大学院 医歯学総合研究科 心臓血管・高血圧内科学

X (旧Twitter)

Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University

研究について

研究

学会活動

The 29th Scientific Meeting of the International Society of Hypertension (ISH2022)（2022年10月, Kyoto, Japan）

  • Ohishi M.
  • Session 15.
    Efforts aimed to achieve hypertension zero in community; experience in Makurazaki city.
  • Ohishi M.
  • Luncheon Seminar 12.
    How to achieve optimal BP？－HBP Zero town－.
  • Ohishi M.
  • Sponsored Symposium 4.
    Current Status and Issues of Hypertension in Japan.
  • Yasuda H, Yasuda O, Ohishi M.
  • The factors related to hypertension in young male athletes.
  • Kubozono T, Akasaki Y, Kawasoe S, Ojima S, Kawabata T, Anwar Ahmed Salim, Ikeda Y, Ohishi M.
  • Association between defecation status and blood pressure variability.
  • Higuchi K, Ohishi M.
  • Blood pressure in patients with Fabry disease.
  • Ninomiya Y, Kawasoe S, Kubozono T, Tokushige A, Ichiki H, Ikeda Y, Miyahara H, Tokushige K, Ohishi M.
  • Association between increased abdominal circumference and future development of hypertension in mildly obese middle-aged individuals.
  • Kawasoe S, Kubozono T, Ojima S, Kawabata T, Awar Armed Salim, Ikeda Y, Miyahara H, Tokushige K, Ohishi M.
  • Predictive ability for new-onset chronic kidney diseases by machine learning algorithm using health checkup data.
  • Shibata K, Tokushige A, Nitta M, Akasaki Y, Higuchi K, Ikeda Y, Ohishi M.
  • Hypertension due to Lenvatinib induction.
  • Sakoda T, Akasaki Y, Kawasoe S, Kubozono T, Sasaki Y, Ikeda Y, Ohishi M, Miyahara H, Tokushige K.
  • Factors for new-onset isolated diastolic hypertension and progression to systolic hypertension in Japan.
  • Sakoda T, Akasaki Y, Kawasoe S, Kubozono T, Sasaki Y, Ikeda Y, Ohishi M, Miyahara H, Tokushige K.
  • Differences in risk factors for developing hypertension when hypertension reference values are changed.
  • Uebo S, Ikeda Y, Uchikado Y, Akasaki Y, Ohishi M.
  • Angiotensin II type I receptor signal regulates mitochondrial dynamics, causing muscular mitochondrial dysfunction and sarcopenia under metabolic stress.
  • Uchikado Y, Ikeda Y, Uebo S, Sasaki Y, Akasaki Y, Ohishi M.
  • Angiotensin II type1 receptor inhibition improves vascular senescence through improvement of mitochondrial quality control via CRAF/MEK/ERK pathway.
  • Anwar Ahmed Salim, Kawasoe S, Kubozono T, Ojima S, Kawabata T, Ikeda Y, Miyahara H, Tokushige K, Ohishi M.
  • Associations between uric acid levels and hypertension incidence in an apparently healthy Japanese population.
  • Anwar Ahmed Salim, Kawasoe S, Kubozono T, Ojima S, Kawabata T, Ikeda Y, Miyahara H, Tokushige K, Ohishi M.
  • Metabolic syndrome risk prediction equation and a simple score model derivation and validation in Japanese general population.

PAGE TOP